Assignee
EVER NEURO PHARMA GMBH
AT·2 granted patents·3 pending applications·1 citations·filing 2007–2023
Top patents by PatentIndex Score
5 records- 0160US8034778B2Neuroprotective compounds and uses thereofEVER NEURO PHARMA GMBH·Filed 2007·Granted Oct 11, 2011·1 cites·8 claims
- 0250US2023302080A1Method for producing a mammalian brain protein hydrolysateEVER NEURO PHARMA GMBH·Filed 2021·Application pending·0 cites
- 0348US2025361252A1Apomorphine prodrugs and uses thereofEVER NEURO PHARMA GMBH·Filed 2023·Application pending·0 cites
- 0429US12589118B2Method of prolonging the lifespan of patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) using a cerebrolysin® preparationEVER NEURO PHARMA GMBH·Filed 2018·Granted Mar 31, 2026·0 cites·15 claims
- 0525US2018280465A1Aqueous composition of apomorphine for subcutaneous administrationEVER NEURO PHARMA GMBH·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when EVER NEURO PHARMA GMBH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →